Ketamine Therapy and Mania Risk in Bipolar Disorder

Does Ketamine Trigger Mania in Bipolar Disorder?

Ketamine can trigger a switch into hypomania or mania in some people with bipolar disorder, and this risk is one of the main reasons clinicians screen for bipolar spectrum illness before starting low-dose ketamine treatment. Bipolar disorder is a mood disorder marked by episodes of depression alternating with mania or hypomania, periods of elevated mood, decreased need for sleep, and impulsive behavior. Because ketamine is a rapid-acting antidepressant that alters glutamate signaling in the brain, researchers have long asked whether it could destabilize mood in people prone to mania the way some conventional antidepressants can.

No ketamine or esketamine formulation is FDA-approved for bipolar depression. Esketamine (Spravato) holds approval only for treatment-resistant major depressive disorder and depression with suicidal ideation, and its pivotal trials excluded people with bipolar disorder. Any use of ketamine for bipolar depression, low-dose or otherwise, is off-label, meaning it's prescribed based on a clinician's judgment and the available research rather than a condition-specific FDA approval.

What the Research Says About Mood Switching

The strongest evidence on ketamine and bipolar mania risk comes from small, closely monitored clinical trials rather than large real-world studies. Researchers studying ketamine infusions for bipolar depression have generally required participants to already be stabilized on a mood stabilizer such as lithium or valproate before receiving ketamine, and have tracked mood-switch symptoms using standardized rating scales during and after each session. You can review this body of work through PubMed-indexed studies on ketamine, bipolar depression, and mania.

Within these tightly controlled research settings, treatment-emergent mania has been reported as an uncommon but real event, not a routine side effect. What the trials don't answer is how often mood switching occurs in less-supervised, real-world low-dose maintenance protocols, in patients who aren't on a mood stabilizer, or over the months-to-years timelines that maintenance ketamine treatment can involve. That gap is exactly why bipolar disorder is treated as a condition requiring extra caution rather than an outright bar to treatment.

Bipolar I vs. Bipolar II: Does the Type Matter?

Bipolar I disorder, defined by at least one full manic episode, generally carries more concern for ketamine-related mood switching than bipolar II disorder, which involves hypomania and depressive episodes but no full mania. Clinicians often view a history of full mania, psychotic features during mood episodes, or rapid cycling (four or more mood episodes within a year) as reasons for a more cautious approach or a referral to a psychiatrist experienced in mood disorder pharmacology before ketamine is considered.

Family history matters too. A first-degree relative with bipolar disorder raises a person's own lifetime risk of the condition, which is relevant if someone carries a depression diagnosis but has an undiagnosed bipolar component. This is one reason thorough intake screening, covered in our guide to patient selection criteria for ketamine treatment, asks about family psychiatric history, not just personal diagnosis.

How Clinicians Screen and Safeguard Against Mania Risk

Before prescribing low-dose ketamine, clinicians typically take a full psychiatric history that screens for past manic or hypomanic episodes, current mood-stabilizer use, and family history of bipolar disorder. This screening process is part of the broader screening and contraindications review that most reputable ketamine programs complete before a first dose.

• Confirming any existing bipolar diagnosis is stable and, in most cases, that the person is already on an effective mood stabilizer
• Reviewing personal and family history of mania, hypomania, or psychosis
• Starting at a low dose and titrating slowly rather than escalating quickly
• Scheduling closer follow-up in the first several sessions to catch early mood-switch signs

Because ketamine is often used alongside other psychiatric medications, it's also worth understanding how it interacts with common prescriptions, see our overview of ketamine and SSRIs, since medication changes made around the same time as starting ketamine can make it harder to tell which drug is responsible for a mood shift.

Monitoring for Mood Switching During Treatment

Tracking mood between sessions is one of the most practical tools for catching an early switch before it becomes a full manic episode. Keeping a simple log of sleep, energy, irritability, and impulsivity, outlined in our guide to tracking symptoms between ketamine treatments, gives both the patient and prescriber concrete data instead of relying on memory at the next appointment.

This kind of monitoring becomes more, not less, important as treatment continues into a maintenance ketamine protocol, since mood stability can shift over months even after an initial course was well tolerated. It's also worth reviewing other long-term safety topics that maintenance patients should understand alongside mania risk, including ketamine tolerance and long-term useketamine and bladder health, and ketamine-associated hepatotoxicity risk factors and liver function monitoring.